• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在过去、现在和未来全球、区域和国家 2 型糖尿病的负担:对 2019 年全球疾病负担研究的系统分析。

The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019.

机构信息

Department of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Shantou University Medical College, Shantou, Guangdong, China.

出版信息

Front Endocrinol (Lausanne). 2023 Jul 14;14:1192629. doi: 10.3389/fendo.2023.1192629. eCollection 2023.

DOI:10.3389/fendo.2023.1192629
PMID:37522116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10376703/
Abstract

AIM

To report the global, regional, and national burden of type 2 diabetes mellitus (T2DM) in 2019, assess its trends in the past, and forecast its trends in the future.

METHODS

The main data source was the Global Burden of Disease 2019 database. We assessed the changes in T2DM burden from 1990 to 2019 with joinpoint regression analysis. Age-period-cohort analysis was used to forecast the T2DM incidence and mortality rate from 2020 to 2034.

RESULTS

The burden of T2DM has increased from 1990 to 2019 generally. The low-middle socio-demographic index (SDI) region had the highest increase in age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (ASDR) due to T2DM. Nationally, the increase in ASIR (r=0.151, p=0.046) and the decrease in ASMR (r=0.355, p<0.001) were positively correlated with SDIs. In 2019, the global ASIR, ASPR, ASMR, ASDR due to T2DM were 259.9 (95% UI 240.3-281.4), 5282.9 (95% UI 4853.6-5752.1), 18.5 (95% UI 17.2-19.7), and 801.5 (95% UI 55477000-79005200) per 100,000 population, respectively. Additionally, the ASIR (r=0.153, p=0.030) and ASPR (r=0.159, p=0.024) of T2DM were positively correlated with SDIs, while ASMR (r=-0.226, p=0.001) and ASDR (r=-0.171, p=0.015) due to T2DM were negatively correlated with SDIs. The ASIR was estimated to increase to 284.42, and ASMR was estimated to increase to 19.1 from 2030 to 2034, per 100,000 population.

CONCLUSION

Globally, the burden of T2DM has increased in the past and was forecast to continue increasing. Greater investment in T2DM prevention is needed.

摘要

目的

报告 2019 年全球、区域和国家 2 型糖尿病(T2DM)负担,评估过去的变化趋势,并预测未来的变化趋势。

方法

主要数据来源是全球疾病负担 2019 数据库。我们使用 Joinpoint 回归分析评估了 1990 年至 2019 年 T2DM 负担的变化情况。年龄-时期-队列分析用于预测 2020 年至 2034 年 T2DM 的发病率和死亡率。

结果

T2DM 的负担总体上从 1990 年增加到 2019 年。中低收入社会人口指数(SDI)地区因 T2DM 导致的年龄标准化发病率(ASIR)、年龄标准化患病率(ASPR)、年龄标准化死亡率(ASMR)和年龄标准化伤残调整生命年(ASDR)增幅最大。在全国范围内,ASIR 的增加(r=0.151,p=0.046)和 ASMR 的下降(r=0.355,p<0.001)与 SDI 呈正相关。2019 年,全球 T2DM 的 ASIR、ASPR、ASMR 和 ASDR 分别为 259.9(95%UI 240.3-281.4)、5282.9(95%UI 4853.6-5752.1)、18.5(95%UI 17.2-19.7)和 801.5(95%UI 55477000-79005200)/100000 人。此外,T2DM 的 ASIR(r=0.153,p=0.030)和 ASPR(r=0.159,p=0.024)与 SDI 呈正相关,而 T2DM 的 ASMR(r=-0.226,p=0.001)和 ASDR(r=-0.171,p=0.015)与 SDI 呈负相关。预计到 2030 年至 2034 年,每 100000 人 T2DM 的 ASIR 将增加到 284.42,ASMR 将增加到 19.1。

结论

在全球范围内,T2DM 的负担在过去有所增加,并预计将继续增加。需要加大对 T2DM 预防的投资。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/5c816ab8b0aa/fendo-14-1192629-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/b845b18486c6/fendo-14-1192629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/c80709bdc915/fendo-14-1192629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/0a4060a91c16/fendo-14-1192629-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/27999708ae48/fendo-14-1192629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/5c816ab8b0aa/fendo-14-1192629-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/b845b18486c6/fendo-14-1192629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/c80709bdc915/fendo-14-1192629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/0a4060a91c16/fendo-14-1192629-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/27999708ae48/fendo-14-1192629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ae/10376703/5c816ab8b0aa/fendo-14-1192629-g005.jpg

相似文献

1
The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019.在过去、现在和未来全球、区域和国家 2 型糖尿病的负担:对 2019 年全球疾病负担研究的系统分析。
Front Endocrinol (Lausanne). 2023 Jul 14;14:1192629. doi: 10.3389/fendo.2023.1192629. eCollection 2023.
2
Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.中国 1990 年至 2021 年以及 15 年预测的子宫癌负担:系统分析与全球水平的比较。
Reprod Health. 2024 Oct 10;21(1):144. doi: 10.1186/s12978-024-01882-2.
3
Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021.1990 - 2021年全球、区域和国家缺血性卒中负担:基于2021年全球疾病负担研究数据的分析
EClinicalMedicine. 2024 Jul 27;75:102758. doi: 10.1016/j.eclinm.2024.102758. eCollection 2024 Sep.
4
Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年全球、区域和国家的地中海贫血负担:全球疾病负担研究2021的系统分析
EClinicalMedicine. 2024 May 6;72:102619. doi: 10.1016/j.eclinm.2024.102619. eCollection 2024 Jun.
5
Trends of the burden of type 2 diabetes mellitus attributable to high body mass index from 1990 to 2019 in China.中国 1990 年至 2019 年归因于高身体质量指数的 2 型糖尿病负担趋势。
Front Endocrinol (Lausanne). 2023 May 31;14:1193884. doi: 10.3389/fendo.2023.1193884. eCollection 2023.
6
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的食管癌负担:与全球数据的比较。
Thorac Cancer. 2023 Aug;14(24):2361-2407. doi: 10.1111/1759-7714.15026. Epub 2023 Jul 17.
7
Global trends of interstitial lung diseases from 1990 to 2019: an age-period-cohort study based on the Global Burden of Disease study 2019, and projections until 2030.1990年至2019年期间间质性肺疾病的全球趋势:基于2019年全球疾病负担研究的年龄-时期-队列研究及到2030年的预测
Front Med (Lausanne). 2023 Jul 24;10:1141372. doi: 10.3389/fmed.2023.1141372. eCollection 2023.
8
The long-term spatio-temporal trends in burden and attributable risk factors of major depressive disorder at global, regional and national levels during 1990-2019: a systematic analysis for GBD 2019.1990-2019 年全球、地区和国家层面主要抑郁症负担及归因风险因素的长期时空趋势:GBD 2019 的系统分析。
Epidemiol Psychiatr Sci. 2024 May 20;33:e28. doi: 10.1017/S2045796024000295.
9
Global, regional, and national burden and trends of early-onset tracheal, bronchus, and lung cancer from 1990 to 2019.1990年至2019年全球、区域和国家早发性气管、支气管和肺癌的负担及趋势
Thorac Cancer. 2024 Mar;15(8):601-613. doi: 10.1111/1759-7714.15227. Epub 2024 Feb 1.
10
The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.204 个国家和地区非酒精性脂肪性肝病的全球、区域和国家负担及趋势:基于 2019 年全球疾病负担研究的分析。
JMIR Public Health Surveill. 2022 Dec 12;8(12):e34809. doi: 10.2196/34809.

引用本文的文献

1
The Complex Gene-Carbohydrate Interaction in Type 2 Diabetes: Between Current Knowledge and Future Perspectives.2型糖尿病中复杂的基因-碳水化合物相互作用:当前认知与未来展望
Nutrients. 2025 Jul 17;17(14):2350. doi: 10.3390/nu17142350.
2
The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus.脂肪组织调节异常对2型糖尿病的影响。
Biomedicines. 2025 Jul 19;13(7):1770. doi: 10.3390/biomedicines13071770.
3
The disproportionate burden of pulmonary arterial hypertension among the elderly: global, regional, and national trends from 1990 to 2021-findings from the 2021 global burden of disease study.

本文引用的文献

1
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes.度拉糖肽与利拉鲁肽治疗 2 型糖尿病的药物经济学分析(CER)。
Front Endocrinol (Lausanne). 2023 Jan 23;14:1054946. doi: 10.3389/fendo.2023.1054946. eCollection 2023.
2
Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults.老年成年人中糖尿病诊断年龄和病程与发病率及死亡率的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2232766. doi: 10.1001/jamanetworkopen.2022.32766.
3
The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990-2019: An analysis of the Global Burden of Disease Study.
老年人肺动脉高压的负担过重:1990年至2021年的全球、区域和国家趋势——2021年全球疾病负担研究的结果
Front Cardiovasc Med. 2025 Jul 8;12:1564785. doi: 10.3389/fcvm.2025.1564785. eCollection 2025.
4
Effects of inflammation on hypoxic renal tubular epithelial cell injury under high-glucose conditions and the regulatory role of miR-125b.炎症对高糖条件下缺氧肾小管上皮细胞损伤的影响及miR-125b的调控作用
Sci Rep. 2025 Jul 1;15(1):21248. doi: 10.1038/s41598-025-05701-x.
5
Identification of stable reference genes and differential miRNA expression in Sri Lankan type 2 diabetes mellitus patients: a cross-sectional study.斯里兰卡2型糖尿病患者中稳定参考基因的鉴定及微小RNA表达差异:一项横断面研究。
Front Endocrinol (Lausanne). 2025 Jun 12;16:1554827. doi: 10.3389/fendo.2025.1554827. eCollection 2025.
6
Epidemiological and demographic drivers of ischemic stroke attributed to high fasting plasma glucose from 1990 to 2021: findings from the 2021 global burden of disease study.1990年至2021年空腹血糖升高所致缺血性卒中的流行病学和人口统计学驱动因素:2021年全球疾病负担研究的结果
Front Public Health. 2025 May 19;13:1511518. doi: 10.3389/fpubh.2025.1511518. eCollection 2025.
7
The Future Diabetes Mortality: Challenges in Meeting the 2030 Sustainable Development Goal of Reducing Premature Mortality from Diabetes.未来糖尿病死亡率:实现2030年降低糖尿病过早死亡率可持续发展目标面临的挑战
J Clin Med. 2025 May 12;14(10):3364. doi: 10.3390/jcm14103364.
8
Expert Opinion on Optimizing Suboptimal Basal Insulin Titration in India: Addressing Challenges and Leveraging Digital Solutions.关于优化印度次优基础胰岛素滴定的专家意见:应对挑战并利用数字解决方案
Diabetes Ther. 2025 May 20. doi: 10.1007/s13300-025-01747-2.
9
Global Burden of Disease Due to High Body Mass Index and Projections to 2040: A Study Based on the Global Burden of Disease Study 2019.高体重指数所致的全球疾病负担及到2040年的预测:基于《2019年全球疾病负担研究》的一项研究
Int J Health Plann Manage. 2025 Sep;40(5):1069-1082. doi: 10.1002/hpm.3946. Epub 2025 May 14.
10
Statin use and risk of HCC in patients with MASLD and T2DM: an umbrella review and meta-analysis.非酒精性脂肪性肝病和2型糖尿病患者使用他汀类药物与肝细胞癌风险:一项综述和荟萃分析
BMC Cancer. 2025 May 14;25(1):875. doi: 10.1186/s12885-025-14299-2.
204 个国家和地区 1990-2019 年归因于高身体质量指数的 2 型糖尿病全球负担:全球疾病负担研究分析。
Front Public Health. 2022 Sep 9;10:966093. doi: 10.3389/fpubh.2022.966093. eCollection 2022.
4
The Prevalence of Diabetes among Hypertensive Polish in Relation to Sex-Difference in Body Mass Index, Waist Circumference, Body Fat Percentage and Age.波兰高血压患者中糖尿病的患病率与性别差异、体重指数、腰围、体脂百分比和年龄的关系。
Int J Environ Res Public Health. 2022 Aug 2;19(15):9458. doi: 10.3390/ijerph19159458.
5
Incidence, Morbidity and years Lived With Disability due to Type 2 Diabetes Mellitus in 204 Countries and Territories: Trends From 1990 to 2019.204 个国家和地区 2 型糖尿病发病率、患病率和伤残调整生命年变化趋势:1990 年至 2019 年趋势。
Front Endocrinol (Lausanne). 2022 Jul 11;13:905538. doi: 10.3389/fendo.2022.905538. eCollection 2022.
6
Prevalence and impact of polypharmacy in older patients with type 2 diabetes.2 型糖尿病老年患者中药物滥用的流行情况及其影响。
Aging Clin Exp Res. 2022 Sep;34(9):1969-1983. doi: 10.1007/s40520-022-02165-1. Epub 2022 Jun 20.
7
Microbiota in health and diseases.肠道菌群与健康和疾病。
Signal Transduct Target Ther. 2022 Apr 23;7(1):135. doi: 10.1038/s41392-022-00974-4.
8
Incidence of newly diagnosed diabetes after Covid-19.新冠病毒感染后新发糖尿病的发病率。
Diabetologia. 2022 Jun;65(6):949-954. doi: 10.1007/s00125-022-05670-0. Epub 2022 Mar 16.
9
Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019.2019 年全球疾病负担研究:1990 年至 2019 年 204 个国家和地区 2 型糖尿病及其归因风险因素的患病率、死亡率和伤残调整生命年(DALYs)。
Front Endocrinol (Lausanne). 2022 Feb 25;13:838027. doi: 10.3389/fendo.2022.838027. eCollection 2022.
10
Global prevalence and trends in hypertension and type 2 diabetes mellitus among slum residents: a systematic review and meta-analysis.全球贫民窟居民中高血压和 2 型糖尿病的患病率和趋势:系统评价和荟萃分析。
BMJ Open. 2022 Feb 24;12(2):e052393. doi: 10.1136/bmjopen-2021-052393.